Learn More
Gibco™ Human LIF Recombinant Protein
Beschreibung
Reconstitution: Centrifuge the vial briefly, before opening to bring the contents to the bottom. Reconstitute the lyophilized protein in sterile, distilled water or appropriate buffered solution containing 0.1% BSA to regain full activity. Apportion there constituted protein into working aliquots and store at -20°C. Make any further dilutions of the reconstituted protein in buffered solution containing a carrier protein, such as PBS with 0.1% BSA. Storage: Store the lyophilized protein at 2-8°C, preferably desiccated. Upon reconstitution, apportion into working aliquots and store at -20°C. Avoid repeated freeze-thaw cycles.
Spezifikation
Spezifikation
| Zugriffsnummer | P15018 |
| Zur Verwendung mit (Anwendung) | Control, ELISA, Functional Assay, Immunohistochemistry, Western Blot |
| Zusammensetzung | protein with no preservative |
| Gen-ID (Entrez) | 3976 |
| Molekulargewicht | 21 kDa |
| Name | Human LIF |
| Reinigungsverfahren | Sequential Chromatography |
| Menge | 10 μg |
| Endotoxin-Konzentration | <0.1 ng/μg |
| Gen-Alias | CDF; cholinergic differentiation factor; cholinergic neuronal differentiation factor; d factor; DIA; differentiation inhibitory activity; differentiation-inducing factor; differentiation-stimulating factor; Emfilermin; hepatocyte-stimulating factor III; HILDA; human interleukin in DA cells; leukemia inhibitory factor; leukemia inhibitory factor (cholinergic differentiation factor); LIF; Melanoma-derived LPL inhibitor; MLPLI; myeloid leukaemia inhibitory factor |
| Mehr anzeigen |
Indem Sie auf Absenden klicken, erklären Sie sich damit einverstanden, dass Fisher Scientific sich mit Ihnen in Verbindung setzen kann, um Ihr Feedback in diesem Formular zu bearbeiten. Wir werden Ihre Informationen nicht für andere Zwecke weitergeben. Alle bereitgestellten Kontaktinformationen werden in Übereinstimmung mit unserer Datenschutzrichtlinie aufbewahrt. Datenschutzrichtlinie.